GBL is delighted with the appointment of Frans van Houten, former CEO of Philips, as a non-executive Supervisory Board Member. A recognised visionary in healthcare innovation and technology sectors, Frans van Houten will leverage his leadership skills and insights to significantly enhance Affidea's aspirations for #growth and #digital innovation. Michal Chalaczkiewicz, Chairman of Affidea’s Supervisory Board and Investment Partner at GBL, stated: “We are delighted to welcome Frans van Houten to Affidea’s Supervisory Board, joining the other distinguished members. His appointment represents a significant addition, embodying GBL's commitment as a shareholder in Affidea. We are looking forward to working alongside Frans and leveraging his expertise as we build the future path of this exciting journey together with the teams at Affidea and GBL”. Frans van Houten joins the Supervisory Board alongside Affidea management, GBL representatives and Dimitris Moulavasilis, who joined as a non-executive Director in 2022. Dimitris Moulavasilis is the current CEO of Diaverum and former CEO of Affidea. We invite you to read more here: https://lnkd.in/dWvx8fTC
Welcome on board, Frans!
CPO Philips. Triple bottom line business executive … people, planet, profit.
1yCongratulations Frans van Houten on the appointment to this role.